AGP Picks
View all

Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

Press releases published on September 9, 2026

NANOBIOTIX to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
NANOBIOTIX Participera à la Conférence H.C. Wainwright 28th Annual Global Investment
Century Therapeutics Appoints Joseph Truitt to Board of Directors
 MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference
First Infant Data from Ascendis Trial of Once-Weekly TransCon CNP (Navepegritide) Presented at ESPE 2026
Genelux Announces Publication of a Deep and Durable Response in a Platinum-relapsed Small Cell Lung Cancer Patient Following Systemically Delivered Olvi-Vec-Primed Immunochemotherapy
Sports Medicine Market to reach USD 15.60 Billion by 2035 at 7.29% CAGR
Telemedicine Market to reach USD 479.67 Billion by 2035 at 14.18% CAGR
Zoher F. Kapasi, PhD, PT, Named Provost of Thomas Jefferson University
Hardcore Teardown: How GIHOMO’s Oxygen Delivery & Safety Systems Maximize Hyperbaric Chamber Output
AI Transforms Outpatient Surgery Through Smarter Planning and Safer Care
Dark Horse Consulting Group Marks the Opening of Its Shanghai Office with Ribbon Cutting Ceremony
Sobi Receives US FDA Fast Track Designation for pacritinib in VEXAS Syndrome
Fast Company nombra a Visory Health en su lista de Mejores Lugares de Trabajo para Innovadores de 2026
Association of Clinical Research Professionals Opens Applications for 2026–27 Scholarships and Grants Program
Trethera Congratulates Board Director Dr. Timothy R. Donahue on Appointment to Senior Leadership Roles at Weill Cornell Medicine and NewYork-Presbyterian
Ladies of Porter Ranch Partners with American Red Cross for Community Blood Drive During Sickle Cell Awareness Month
OSE Immunotherapeutics Welcomes First Patient Dosed by Veloxis in the Phase 2 RENGEVITY-201 Trial Evaluating Pegrizeprument (VEL-101) for the Prevention of Organ Rejection in Kidney Transplant Recipients

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Observer Falkland Islands

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.